Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Gemzar (Gemcitabine).
Blood clotting: Gemzar (Gemcitabine) can reduce the number of platelet cells in the blood. Your doctor will monitor the number of platelets in your blood with regular blood tests while you are using Gemzar (Gemcitabine). Platelets help the blood to clot, and a shortage could make you bleed more easily. Tell your doctor of any signs that your blood is not clotting as quickly. Such symptoms may include black and tarry stools, nosebleeds, bleeding gums, blood in the urine, easy bruising, or cuts that won't stop bleeding.
Fever and flu-like symptoms: Gemzar (Gemcitabine) can cause a fever and flu-like symptoms (chills, feeling unwell) that are not associated with an infection. Your doctor may prescribe Acetaminophen to help treat this reaction.
Infection: As well as killing cancer cells, Gemzar (Gemcitabine) can reduce the number of cells that fight infection in the body (white blood cells). Avoid contact with people who have contagious infections and tell your doctor if you begin to notice signs of an infection, such as fever or chills. Your doctor will monitor the number of white blood cells in your blood with regular blood tests while you are using Gemzar (Gemcitabine).
Kidney problems: Rarely, Gemzar (Gemcitabine) can cause a rapid breakdown of red blood cells that can be associated with kidney failure and may be fatal. Your doctor will monitor you for this while you are receiving Gemzar (Gemcitabine). People who have kidney problems should discuss with their doctor how Gemzar (Gemcitabine) may affect their medical condition, how their medical condition may affect the dosing and effectiveness of Gemzar (Gemcitabine), and whether any special monitoring is needed.
Liver problems: Gemzar (Gemcitabine) may reduce liver function and can cause liver failure. If you have liver problems, discuss with your doctor how Gemzar (Gemcitabine) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Gemzar (Gemcitabine), and whether any special monitoring is needed.
If you experience symptoms of liver problems such as fatigue, feeling unwell, loss of appetite, nausea, yellowing of the skin or whites of the eyes, dark urine, pale stools, abdominal pain or swelling, and itchy skin, contact your doctor immediately.
Lung inflammation: Lung inflammation, causing difficulty breathing has occurred rarely in some people taking Gemzar (Gemcitabine). This complication can be serious and sometimes fatal. If you experience new or worsening shortness of breath or cough (with or without fever) at any time while you are taking Gemzar (Gemcitabine) contact your doctor immediately.
Reversible Posterior Leukoencephalopathy Syndrome (RPLS): This is a rare disease of the brain that may occur when using medications like Gemzar (Gemcitabine). If you have had a previous episode of RPLS, Gemzar (Gemcitabine) may not be an appropriate medication for you. If you experience signs and symptoms of RPLS, such as headache, seizures, change in awareness or consciousness or vision changes, contact your doctor immediately.
Pregnancy: Gemzar (Gemcitabine) should not be used during pregnancy. Effective birth control should be used while receiving Gemzar (Gemcitabine). Gemzar (Gemcitabine) may harm the baby if used during pregnancy. If you become pregnant while taking Gemzar (Gemcitabine), contact your doctor immediately.
Breast-feeding: It is not known if Gemzar (Gemcitabine) passes into breast milk. Women receiving Gemzar (Gemcitabine) should not breast-feed.
Children: The safety and effectiveness of using Gemzar (Gemcitabine) have not been established for children.